AstraZeneca diabetes drug cuts heart risks in major study
AstraZeneca said on Monday its diabetes drug Farxiga met a key goal in a major clinical study designed to show the heart-protecting benefits of the medicine.
from Reuters: Health News https://reut.rs/2OM9soT
http://bit.ly/2zwRqiM